Clinical Scorecard: Preoperative Prediction of Axillary Pathological Complete Response in Breast Cancer Using MRI-Based Habitat Radiomics After Neoadjuvant Therapy: A Multicenter Analysis

At a Glance

Key Highlights

• Development of a nomogram integrating MRI-based habitat radiomics and clinical variables
• Achieved AUCs of 0.845 in training cohort and 0.755 in external validation cohort
• Promising tool for noninvasive prediction of apCR post-neoadjuvant therapy
• Potential to assist in individualized axillary risk stratification
• Addresses limitations of traditional radiomics by capturing intratumoral heterogeneity

Guideline-Based Recommendations

Diagnosis

• Utilize MRI for assessment of treatment response after neoadjuvant therapy
• Integrate radiomic features with clinical data for improved predictive accuracy

Management

• Consider noninvasive tools for evaluating residual axillary lymph node disease
• De-escalate axillary surgery in selected patients achieving apCR

Monitoring & Follow-up

• Regularly assess treatment response using MRI and radiomics
• Monitor for potential residual disease post-neoadjuvant therapy

Risks

• Invasive procedures like axillary lymph node dissection carry risks of morbidity
• False-negative rates in less invasive approaches may necessitate further intervention

Patient & Prescribing Data

Women with invasive breast cancer and biopsy-proven axillary lymph node metastasis

Patients received 6 or 8 cycles of neoadjuvant therapy prior to MRI assessment

Clinical Best Practices

• Employ dynamic contrast-enhanced MRI for detailed tumor assessment
• Utilize habitat radiomics to capture spatial heterogeneity within tumors
• Incorporate clinicopathological variables into predictive models

Related Resources & Content

• Study Reference